348 related articles for article (PubMed ID: 31210311)
1. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
Yu DJ; Li YH; Zhong M
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
[TBL] [Abstract][Full Text] [Related]
2. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
3. LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway.
Tan LJ; Liu JT; Yang M; Ju T; Zhang YS
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1870-1876. PubMed ID: 32141556
[TBL] [Abstract][Full Text] [Related]
4. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of lncRNA NCK1-AS1 predicts poor prognosis and contributes to non-small cell lung cancer proliferation by regulating CDK1.
Zha LF; Zhang LD; Pan HM; Ma HD
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1351-1357. PubMed ID: 33629305
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT.
Ren P; Zhang H; Chang L; Hong XD; Xing L
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3686-3693. PubMed ID: 32329844
[TBL] [Abstract][Full Text] [Related]
7. LncRNA DDX11-AS1 promotes cell growth, migration and invasion through regulating epithelial-mesenchymal transition in breast cancer.
Xi X; Yang F; Ding Z; Zhuang H; Yuan H
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):40-44. PubMed ID: 38678629
[TBL] [Abstract][Full Text] [Related]
8. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CACNA1G-AS1 promotes cell migration, invasion and epithelial-mesenchymal transition by HNRNPA2B1 in non-small cell lung cancer.
Yu PF; Kang AR; Jing LJ; Wang YM
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):993-1002. PubMed ID: 29509247
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
11. LINC01093 promotes proliferation and invasion of non-small cell lung cancer cells via targeting akt signaling pathway.
Wang ZX; Xu ZN; Sun HB; Wang Y; Han ZF; Yu Y; Han XL; Yin YY; Xu L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):222-229. PubMed ID: 31957835
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p.
Yu X; Lin Q; Liu F; Yang F; Mao J; Chen X
Int J Immunopathol Pharmacol; 2020; 34():2058738420958947. PubMed ID: 32969763
[TBL] [Abstract][Full Text] [Related]
13. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
Cui F; Luo P; Bai Y; Meng J
Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
[TBL] [Abstract][Full Text] [Related]
14. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
Yue QY; Zhang Y
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of long non-coding RNA ZEB2-AS1 may predict poor prognosis and promote the migration, invasion, and epithelial-mesenchymal transition of tumor cells in non-small cell lung cancer.
Xu H; Yu B; Shen W; Jin C; Wang L; Xi Y
Int J Biol Markers; 2020 Sep; 35(3):29-35. PubMed ID: 32611283
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion.
Dong YZ; Meng XM; Li GS
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2671-2679. PubMed ID: 29771418
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer.
Wu Y; Lyu H; Liu H; Shi X; Song Y; Liu B
Sci Rep; 2016 Aug; 6():31093. PubMed ID: 27489122
[TBL] [Abstract][Full Text] [Related]
19. lncRNA AFAP1-AS1 Promotes Migration and Invasion of Non-Small Cell Lung Cancer via Up-Regulating IRF7 and the RIG-I-Like Receptor Signaling Pathway.
Tang XD; Zhang DD; Jia L; Ji W; Zhao YS
Cell Physiol Biochem; 2018; 50(1):179-195. PubMed ID: 30278439
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ADAMTS9-AS1 knockdown restricts cell proliferation and EMT in non-small cell lung cancer.
Li Z; Yue G; Zhang T; Wu J; Tian X
Histol Histopathol; 2021 Oct; 36(10):1063-1072. PubMed ID: 34085704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]